These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25131461)

  • 1. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
    Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve Growth Factor Levels are Associated with Overactive Bladder Symptoms and Long-Term Treatment Outcome after Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia.
    Hu H; Zhang W; Liu X; Wang H; Fang Z; Liang C; Wang T; Xu K
    J Urol; 2018 Sep; 200(3):620-625. PubMed ID: 29630981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder.
    Wang LW; Han XM; Chen CH; Ma Y; Hai B
    Int Urol Nephrol; 2014 Feb; 46(2):341-7. PubMed ID: 23982767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary prostaglandins E2 correlates to overactive bladder symptoms in patients with benign prostatic hyperplasia].
    Zhang YJ; Bai Q
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):244-8. PubMed ID: 24738462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive Bladder.
    Matsuo T; Miyata Y; Araki K; Mukae Y; Otsubo A; Ohba K; Sakai H
    Low Urin Tract Symptoms; 2020 Jan; 12(1):47-53. PubMed ID: 31407871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study.
    Li J; Yi XY; Chen ZY; Chen B; Huang Y; Liao DZ; Wang PZ; Cao DH; Ai JZ; Liu LR
    Asian J Androl; 2024 Jan; 26(1):112-118. PubMed ID: 37594295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Wada N; Watanabe M; Kita M; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2012 Jun; 31(5):659-63. PubMed ID: 22488529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity?
    Fan YH; Lin CC; Lin AT; Chen KK
    J Chin Med Assoc; 2011 Oct; 74(10):455-9. PubMed ID: 22036137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the associations of mucosal P2Y6 receptor expression and urinary ATP and ADP concentrations, with symptoms of overactive bladder.
    Firouzmand S; Ajori L; Towse J; Allameh F; Najafi S; Javed S; John B; Langley SEM; Fry CH; Young JS
    Neurourol Urodyn; 2020 Mar; 39(3):926-934. PubMed ID: 32049380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
    Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study.
    Kwon O; Lee HE; Bae J; Oh JK; Oh SJ
    Urology; 2014 Mar; 83(3):581-5. PubMed ID: 24373317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia.
    Lee D; Koo KC; Yoo JW; Lee KS
    Low Urin Tract Symptoms; 2022 Jan; 14(1):35-40. PubMed ID: 34323012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of combination therapy of tamsulosin and solifenacin for mild and moderate benign prostatic hyperplasia with overactive bladder].
    Gao ZW; Xin SY; Zhang JG; Ren XQ; Shang YF; Zhang W; Li HB; Xiao F; Shao CS
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):239-43. PubMed ID: 24738461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
    Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
    Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
    Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
    Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.